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Abstract  
Introduction: Onchocerciasis is one of the leading infectious causes of blindness affecting over 37 million people of which 99% are in Africa. The 
purpose of this study was to determine the prevalence of onchocerciasis in the Fundong Health District, a locality where community-directed 
treatment  with  ivermectin  has  been  carried  out  for  6  consecutive  years.  Methods:  Questionnaires  covering  participants’  identity,  Rapid 
Epidemiological Assessment (REA) for onchocerciasis and parasitological parameters were distributed to participants. Skin snip (SS) was collected 
for laboratory investigation. Results: A total of 404 participants belonging to 200 households were randomly selected from the Fundong Health 
District, of which 134 (33.2%) were males and 270(66.8%) were females, 14 (3.5%) had microfilaredermia and 15(3.7%) had nodules. There was 
no significant difference in the prevalence of microfilaredermia with respect to age of participants (X
2=2.749, P=0.601). There was however a 
statistically significant difference in the prevalence of nodule and impaired vision/eye itching (IVIE) with respect to age (X
2=24.67, P<0.001). The 
greatest rate of infection was found among farmers (2.5%) followed by students (0.7%) and businessmen (0.25%). Conclusion: This study 
shows that the study area is now hypo-endemic for onchocerciasis, following 6 years of continuous treatment with ivermectin. Careful monitoring 
of onchocerciasis should however be continued to avoid that the area returns to its initial hyper endemicity.  
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Introduction 
 
Onchocerciasis, commonly known as river blindness is a parasitic infection caused by the lymph space and subcutaneous-dwelling Onchocerca 
volvulus. The disease is transmitted by black flies of genius Simulium. It produces untold hardship characterized by severe pruritus, formation of 
nodules (onchocercomas), changes in skin pigmentation, loss of skin elasticity, revolting fleshy deformities (hanging groin or adenolymphocele), 
impaired vision and blindness due to invasion of the eyes by microfilaria. The disease remains a major public health and socioeconomic problem to 
the African continent [1].  
  
Onchocerciasis is one of the leading infectious causes of blindness in Africa [2-4]. For many years, onchocerciasis was thought to have affected 17 
million people [5]. Recently, this figure was estimated to have risen to more than 37 million [6] as more attention was paid to remote areas in 
Central African countries. According to WHO [7], onchocerciasis has not caused a single death but the global burden is 987,000 disability adjusted 
life years (DALYs). The disease has been found to significantly reduce the lifespan of infected people. Nigeria, Chad, Sudan, Central African 
Republic and Cameroon register high incidences where more than 60% of the population is infected [8].  
  
In 1995, the WHO launched the African programme for Onchocerciasis Control (APOC) that was intended to eliminate onchocerciasis from the 
African continent through Community Directed Treatment with Ivermectin (CDTI) in the next 12years [9]. However following the 2006 and 2007 
progress report, the APOC was extended to 2015 [10].  
  
Rapid Epidemiological Mapping for Onchocerciasis, (REMO) has shown that the disease is endemic in Cameroon [11,12]. Rapid Epidemiological 
Assessment(REA) for onchocerciasis and Rapid Assessment Procedures for Loiasis (RAPLOA) [13,14] have been used in combination to ensure safe 
and effective CDTI, owing to serious adverse events (SAEs) noticed in Loa loa and Onchocerca volvulus co-endemic areas [15-17]. The only 
current control measure is CDTI [18]. In this perspective the purpose of this study was to determine the prevalence of onchocerciasis in a region 
where CDTI has been carried out for at least 6 consecutive years, in order to evaluate the impact of ivermectin treatment in an initially hyper-
endemic area, where more than 45% of the population was infected [19], and extrapolate to other locations with similar treatment profiles.  
  
  
Methods 
 
Study area  
  
Fundong Health District (FHD) is one of the 18 Health Districts in the North West Region (NWR) of Cameroon. It covers a surface area of 145km
2. 
FHD occupies about 4/5th of the land surface area and population of Boyo Division. It is located between latitude 6° 4’and 6°23’ to the North of 
the equator and longitude 10° and 10° 33’ to the East of the Greenwich Meridian. The District headquarter, Fundong, is about 69 km from 
Bamenda, the Regional headquarter, linked by a tarred road. The District is generally hilly with most of the towns located on hills and valleys. It 
has typical savannah grassland vegetation and two distinct climates; the rainy season and dry season. The rainy season which begins from late 
March to early November is characterized by thunder storms, lightening, hailstones and torrential rains. The dry season that extends from mid-
November to mid March and is characterized by cold chilly winds.  
  
Primary visits and participant recruitment  
  
The local authorities and the community leaders were earlier visited and presented with the project as their involvement was a key factor for its 
success. All the houses in the Health District were allocated a number. 200 houses were selected at random, by balloting. This sampling approach 
has already been used elsewhere [20].  
  
The randomly selected households were visited and presented the project. They were however explained that it was not an obligation for them to 
participate  in  the  research  and  neither  was  it  a  pre-requisite  to  accessing  routine  medical  or  other  social  services  publicly  available.  Ethical 
clearance was obtained from the Regional Delegation of Public Health. Written informed consent forms were distributed and explained, and only 
members aged between 15 and 85 years in selected households, who voluntarily accepted to sign and return the consent form were involved in 
the study.  
  
Data collection  
  
Information was obtained from participants by the use of questionnaires. The questionnaire was designed in three parts covering participants’ 
identity, Rapid Epidemiological Assessment (REA) for onchocerciasis and parasitological parameters. Skin snip (SS) specimen was collected from 
every participant. No special collection time was observed as the microfilariae of Onchocerca are non-periodic. Procedures for collection and 
processing  of  skin  snip  (SS)  are  described  elsewhere  [8].  Each  sample  collected  was  immersed  in  normal  saline  solution  in  the  well  of  a 
microtitration tray and the tray was placed on a piece of damp tissue in a Petri dish to prevent the preparation from drying out. Samples collected 
in a household were sent to the hospital laboratory before we visited the next household.  
  
Statistical analysis  
  
The  statistical  packages,  Epi-Info  6.04 (CDC,  2001)  and  SPSS  version  17.0  were  used  to  analyze  the  results  obtained.  Chi-square  (X
2)  test 
differences were considered significant at P<0.05.  
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Results 
 
A total of 404 participants belonging to 100 households were randomly selected from a map of the village. The age range of the study population 
was 15 to 85 years (median, 41 years); 66.6% were females and farmers represented 44.1%. Majority (87.4%) of the participants had a history of 
ivermectin treatment. The overall prevalence of Microfilaredermia was 3.5% (2.0% in males and 1.5 % in females). Three hundred and forty one 
(84.4%) participants reported to have had some troublesome itching of their bodies either currently or in the past of which 67.5% were either 
visually impaired and/or have had a history of itching of the eyes.  
  
Table 1 shows the prevalence of microfilaredermia, nodules and IVIE in different age groups. There was no significant difference in prevalence of 
microfilaredermia with respect to age (X
2=2.74, P=0.601). The highest prevalence of nodules (2.7%) and IVIE (11.9%) was among participants 
aged above 56 years and there was a statistically significant difference in the distribution of nodules (X
2=24.67, P
2= 19.87, P=0.003) among the 
different age groups.  
  
Table 2 shows the prevalence of microfilaredermia, nodules and IVIE according to participants’ occupation. There was no significant difference in 
the prevalence of microfilaredermia with respect to occupation (X
2=6.22, P=0.10). The highest prevalence of nodules (3.0%) and IVIE (24.8%) 
was among farmers and there was a significant difference in the distribution of nodules (X
2=8.77, P=0.03) and that of IVIE (X
2= 16.00, P=0.014) 
among the different occupational groups.  
  
  
Discussion 
 
This study describes the current situation of onchocerciasis in the population of Fundong Health District in Cameroon after 6 years of continuous 
CDTI. The baseline data on the hyper -endemicity of the area 7 years back was obtained from the 2006 annual health report of the Fundong 
Health District [19]. Participants in this study were selected to be above 15 years of age to maximize the likelihood of involving only people who 
have been in the CDTI programme for the past 6 years, as the purpose of the study was to evaluate the impact of ivermectin treatment in the 
area.  
  
This study shows a prevalence of 3.5% for onchocercal filariasis and demonstrates a transition from hyper to hypo-endemicity following 6 years of 
continuous treatment with ivermectin. The level of endemicity has fallen below 7%, the threshold presented to the APOC by Erasmus University 
researchers [10]. The low prevalence of onchocercal microfilaredermia in the study area despite the presence of abundant fast flowing rivers, black 
flies  and  an  atmosphere  that  favours  the  interaction  between  farmers  and  biting  flies  can  more  likely  be  attributed  to  continuous  CDTI. 
Consultation of the FHD CDTI registers suggests a mean annual therapeutic coverage of 72.5% form 2004 to 2010 (62.4% in 2004, 59.0% in 
2005, 63.1% in 2006, 72.3% in 2007, 80.4% in 2008, 85.2% in 2009 and 2010 respectively). One may argue to attribute the low prevalence of 
the disease to the wide use of doxycycline by the community members as this drug is locally available and easily obtained from street vendors at 
low cost, and regularly prescribed for the treatment of chlamydiasis and other sexually transmitted infections which are among the first five causes 
of morbidity in this area [21]. Even though doxycycline has been shown to treat onchocerciasis by killing Wolbachia endobacteria of Onchocerca 
volvulus [22,23], about 4-6 weeks intensive treatment is needed to kill adult worms [24]. Therefore, despite the fact that some participants had a 
recent history of sexually transmitted infections and doxycycline treatment, the wide and indiscriminate use of doxycycline in the area could not 
have accounted for the drop of prevalence of onchocerciasis.  
  
Prevalence of onchocercomas of 3.7% was observed. These cutaneous nodules were concentrated mainly around and below the waist which is 
typical of African form of onchocerciasis [25]. All individuals with nodules had a history of ivermectin treatment. This prevalence of onchocercomas 
might have been underestimated since not all nodules are usually palpable as some adult worms lie in single masses in the tissues [26]. Majority of 
people who had microfilaredermia, nodules and IVIE were aged above 55 years. This suggests that nodules formation is a characteristic of chronic 
infections and can be linked to intensity and  level of exposure [26]. This also holds true in farmers as they had the highest prevalence of 
onchocercomas and IVIE.  
  
Despite the low prevalence of microfilaredermia a vast majority (84.4%) of study participants complained of frequent skin itching. Host reactions to 
dead microfilaria that usually account for most of the pathogenesis [27] and side effects of ivermectin treatment, including pruritus [28], may not 
be enough account for the observed itching in the study population. Therefore, there can be other underlying causes of itching apart from 
onchocercal infection, such as allergic reactions in the dermis of the skin, fungi or bacterial infections.  
  
Limitations of this study reside the failure to measure the prevalence of infection among ivermectin treated and non-treated individuals and the 
selection of participants; some of those who did not normally respond to previous treatment might not have accepted to sign the consent form.  
  
  
Conclusion 
 
This study shows that the study area is now hypo-endemic for onchocerciasis, following 6 years of continuous treatment with ivermectin. Health 
information, sensitization, mobilization and advocacy will be quite instrumental in creating awareness on the various ways of transmission and how 
possible the disease can bounce back if neglected. Constant epidemiological surveys are needed to monitor the disease in its hypo-endemic state. 
Further findings are needed to determine the prevalence of other filarial species and in this area.  
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Table 1: Prevalence of microfilaredermia, nodules and impaired vision/eye itching (IVIE) in different age groups in 
the Fundong Health District, Cameroon 
Age groups 
Number (%) of  subjects 
with microfilaria(e) 
Number (%) of  subjects 
with nodules 
Number (%) of 
subjects with IVIE 
15-25 (n=91)  3 (0.7)  0 (0.0)  43 (10.6) 
26-35 (n=80)  2(0.5)  1(0.2)  33 (8.2) 
36-45 (n=77)  1(0.2)  2(0.5)  36 (9.0) 
46 – 55 (n=67)  3(0.7)  1(0.2)  39 (10.0) 
56 and above (n=89)  5 (1.2)  11 (2.7)  48 (11.9) 
Total (n=404)  14 (3.5)  15(3.7)  199 (49.3) 
  
 
 
 
 
 
 
 
 
Table  2:  Prevalence  of  microfilaredermia,  nodules  and  impaired  vision/eye  itching  (IVIE)  according  to  participants’ 
occupation in the Fundong Health District, Cameroon 
Occupation 
Number (%) of  subjects 
with microfilaria(e) 
Number (%) of  subjects 
with nodules 
Number (%) of 
subjects with IVIE 
Farmers (n=178)  10 (2.5)  12 (3.0)  100 (24.8) 
Student (n=75)  3 (0.7)  0(0.0)  38 (9.4) 
Business (n=87)  1 (0.2)  2 (0.5)  35 (8.7) 
Civil servants (n=64)  0 (.0)  1 (0.2)  28 (7.0) 
Total (n=404)  14 (3.5)  15 (3.5)  199 (49.3) 
  
 